Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
31 hedge funds and large institutions have $3.2M invested in Windtree Therapeutics Inc in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
8,100% more call options, than puts
Call options by funds: $328K | Put options by funds: $4K
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
6% less funds holding
Funds holding: 33 → 31 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
60% less capital invested
Capital invested by funds: $8M → $3.2M (-$4.79M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$45.1K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$30.3K |
| 3 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$8.86K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$6.84K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$1.85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.23M |
| 2 |
Millennium Management
New York
|
-$151K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$59.5K |
| 4 |
Renaissance Technologies
New York
|
-$51K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.99K |
WINT Hedge Fund Activity: Q4 2016 in Review
31 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q4 2016, worth a combined $3.2M — down 60% from $8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of WINT and 4 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 8 added.
The largest buyer was Sabby Management, adding an estimated $45.1K. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $1.23M sold.
- 31 institutional investors held Windtree Therapeutics Inc (WINT) as of Q4 2016, down from 33 in Q3 2016.
- Funds reported $3.2M of Windtree Therapeutics Inc stock for Q4 2016, down 60% quarter-over-quarter.
- 4 funds opened new Windtree Therapeutics Inc positions in Q4 2016 and 6 closed out, a net change of -2 holders.
- The largest Windtree Therapeutics Inc buyer in Q4 2016 was Sabby Management, an estimated $45.1K added.
- The largest Windtree Therapeutics Inc seller in Q4 2016 was DAFNA Capital Management, an estimated $1.23M sold.
Based on aggregated 13F filings for Q4 2016.